Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Por um escritor misterioso
Descrição
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial - The Lancet Oncology
Ipilimumab plus nivolumab in patients with symptomatic melanoma brain metastasis requiring corticosteroids - ScienceDirect
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)
PDF) Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
1694-Melanoma metastatic ipilimumab and nivolumab (induction)
Ipilimumab - Wikipedia
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study - The Lancet Oncology
Considerations for First-Line Metastatic Melanoma: Which Treatment Is Best?
MBM - Melanoma Brain Metastases
Immune Checkpoint Inhibitors for Brain Metastases: A Primer for Neurosurgeons. - Document - Gale OneFile: Health and Medicine
Immunotherapy Drugs Shrink Brain Metastases from Melanoma - NCI
de
por adulto (o preço varia de acordo com o tamanho do grupo)
